Osimertinib is a third-generation irreversible EGFR-TKI for NSCLC with EGFR Ex19Del or L858R mutations, anti-CNS metastasis activity.,
Sale!
Lucius
Replica: Third-Gen EGFR-TKI Osimertinib for EGFRm NSCLC
Original price was: $695.00.$536.00Current price is: $536.00.
Osimertinib is a third-generation irreversible EGFR-TKI for NSCLC with EGFR Ex19Del or L858R mutations, anti-CNS metastasis activity.,